03:23 AM EST, 02/10/2025 (MT Newswires) -- G. Walmsley Graham, Director, on January 30, 2025, executed a purchase for 200,000 shares in Akero Therapeutics ( AKRO ) for $9,600,000. Following the Form 4 filing with the SEC, Graham has control over a total of 1,002,168 common shares of the company, with 2,168 shares held directly and 1,000,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025016559/xslF345X05/ownership.xml